Disclosures for "A Case of Immune Checkpoint Inhibitor (ICI) Use in Multiple Sclerosis"
-
Dr. Patel has nothing to disclose.
-
Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.